/

Chassis & Safety Systems

/

Marinus Pharma

Marinus Pharma

Marinus Pharma

Verified Nov 2026

Chassis & Safety Systems

·

United States flag

Radnor, Pennsylvania

·

Since 2003

Marinus Pharma is a biopharmaceutical company founded in 2003 and headquartered in Radnor, Pennsylvania, with 50–100 employees and estimated revenue of $10–50 million. The company develops therapeutics for seizure disorders and neurological conditions, with ZTALMY® (ganaxolone) as its lead FDA-approved product for treating seizures in CDKL5 deficiency disorder. Marinus became a subsidiary of Immedica Pharma AB in February 2025.

Marinus Pharma

Verified Nov 2026

AT A GLANCE

Founded

2003

Headquarters

United States flag

Radnor, Pennsylvania

Employees

50-100

Ownership

Marinus Pharma at a glance

Revenue

$10-50M

Est. band

Employees

50-100

Founded

2003

Headquarters

Radnor, Pennsylvania

Industries

Automotive

Electric Vehicles

Medical

Overview

Marinus Pharma is a biopharmaceutical company founded in 2003 and headquartered in Radnor, Pennsylvania, with 50–100 employees and estimated revenue of $10–50 million. The company develops therapeutics for seizure disorders and neurological conditions, with ZTALMY® (ganaxolone) as its lead FDA-approved product for treating seizures in CDKL5 deficiency disorder. Marinus became a subsidiary of Immedica Pharma AB in February 2025.

At a glance

Attribute

Detail

Founded

2003

Headquarters

Radnor, Pennsylvania

Employees

50-100

Revenue

$10-50M (estimated)

Primary capability

Chassis & Safety Systems

What Marinus Pharma makes

The company manufactures ganaxolone in oral suspension form and is developing additional formulations including intravenous and capsule options to address seizure disorders across multiple care settings.

Products and capabilities described on the company's own site include Suspension (source: marinuspharma.com).

Latest developments

Facilities

Marinus Pharma is headquartered in Radnor, Pennsylvania. Public sources also reference these locations:

Company details

Marinus serves healthcare providers, caregivers, and patients with seizure and neurological conditions, and operates a facility in Branford, Connecticut in addition to its Pennsylvania headquarters. Marinus Pharma was founded in 2003, has an estimated 50-100 employees, and is headquartered in Radnor, Pennsylvania.

Frequently asked questions

What does Marinus Pharma make?

Marinus Pharma is a biopharmaceutical company founded in 2003 and headquartered in Radnor, Pennsylvania, with 50–100 employees and estimated revenue of $10–50 million. The company develops therapeutics for seizure disorders and neurological conditions, with ZTALMY® (ganaxolone) as its lead FDA-approved product for treating seizures in CDKL5 deficiency disorder. Marinus became a subsidiary of Immedica Pharma AB in February 2025.

Where is Marinus Pharma headquartered?

Marinus Pharma is headquartered in Radnor, Pennsylvania (100 Matsonford Road, Radnor, Pennsylvania, 19087).

When was Marinus Pharma founded?

Marinus Pharma was founded in 2003.

How big is Marinus Pharma?

Marinus Pharma has an estimated 50-100 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Radnor, Pennsylvania (HQ)Headquarters · United States
Radnor, Pennsylvania (HQ)100 Matsonford Road, Radnor, Pennsylvania, 19087, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.